Press Release
Redwood Shores, Calif.—Jun
20, 2016
Oracle today
announced that after a detailed review and selection process, Pfizer has
selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel
Clinical Trial Management and Monitoring Cloud Service to help manage and
monitor its more than 300 clinical trials a year and continue to provide
best-in-class solutions.
“Oracle Health Sciences InForm Cloud Service and Oracle
Siebel Clinical Trial Management and Monitoring Cloud Service can simplify how
we manage both operational and study data for in-house as well as outsourced
studies,” said Rob Goodwin, vice president of Pfizer Global Product
Development, Center of Excellence. “Clinical teams will be able to access study
data through Oracle’s single platform cloud service, eliminating the need to
send data back and forth to CROs, saving us time and reducing the cost of our
clinical studies.”
By using Oracle Health Sciences InForm Cloud Service, Pfizer
will be able to take advantage of over 100,000 investigator sites already
trained in InForm, while increasing site data satisfaction.
The Oracle Health Sciences InForm Cloud Service will enable
Pfizer to have greater control over its data and provide measurable efficiency
and productivity gains in data management and remote monitoring. In addition,
study templates and library management capabilities within Oracle Health
Sciences InForm will enable Pfizer to accelerate the study-build process and
result in faster trial implementation.
“Today, pharma companies are challenged by increasingly
complex global clinical trials,” said Steve Rosenberg, senior vice president
and general manager, Oracle Health Sciences. “With more than 15 years of
electronic data capture experience in the clinical industry, Oracle Health
Sciences helps leading pharmas — such as Pfizer — not only to standardize and
optimize their clinical study processes, but also to be prepared with
value-based clinical innovation solutions that enable them for the future of
data collection.”
Oracle Health Sciences InForm Cloud Service includes both
Oracle Health Sciences InForm and Oracle Health Sciences Data Management
Workbench (DMW) to advance standardized end-to-end clinical data collection and
management processes that help drive greater efficiencies for both internal and
outsourced trials. Utilizing the platform, efficiencies can be gained through
the seamless integration of Oracle Health Sciences InForm, Oracle Health
Sciences Central Designer, and Oracle Health Sciences Data Management Workbench,
enabling data standardization, streamlining collection, consolidation,
cleaning, and transformation.
Pfizer will also use Oracle Siebel Clinical Trial Management
and Monitoring Cloud Service, including Oracle Siebel Clinical Trial Management
System, Oracle Health Sciences Clinical Development Analytics, and risk-based
monitoring (RBM) functionality to provide new insights into trial management
and help increase efficiency of the monitoring workforce. A single set of tools
for internal and outsourced trials can simplify data exchange and the interface
between investigator sites, CRO partners, and Pfizer. With the selection of
Oracle’s platform and RBM solution, Pfizer will be able to execute risk-based
monitoring through an integrated approach.
The Oracle Siebel Clinical Trial Management and Monitoring
Cloud Service, which utilizes Oracle Siebel Clinical Trial Management System
and Oracle Health Sciences Clinical Development Analytics, is a solution that
combines standardized comprehensive clinical trial capabilities, integrated
analytic tools, and data security with a cloud service that enables
organizations to manage clinical trials effectively and economically, as well
as improve CRO and sponsor relationships from early to late stage clinical
trials.
·
To
learn more about Oracle Health Sciences, please connect on Twitter @OracleHealthSci and at facebook.com/oraclehealthsciences.
You can also follow our blog Oracle
Health Science Blog and find us on LinkedIn.
No hay comentarios:
Publicar un comentario
Te agradezco tus comentarios. Te esperamos de vuelta.